66 related articles for article (PubMed ID: 2688310)
1. [Activity of the proteolytic system in patients with breast cancer].
Geshelin SA; Vovchuk SV; Blizniuk BF; Varbanets VF
Vopr Onkol; 1989; 35(10):1191-8. PubMed ID: 2688310
[TBL] [Abstract][Full Text] [Related]
2. Cysteine proteinase inhibitor cystatin A in breast cancer.
Kuopio T; Kankaanranta A; Jalava P; Kronqvist P; Kotkansalo T; Weber E; Collan Y
Cancer Res; 1998 Feb; 58(3):432-6. PubMed ID: 9458085
[TBL] [Abstract][Full Text] [Related]
3. The impact of axillary lymph nodes removed in staging of node-positive breast carcinoma.
Kuru B; Bozgul M
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1328-34. PubMed ID: 16997505
[TBL] [Abstract][Full Text] [Related]
4. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
5. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
[TBL] [Abstract][Full Text] [Related]
6. Activity of cysteine proteases and their inhibitors in the lymph nodes of larynx cancer patients.
Siewiński M; Berdowska I; Mikulewicz W; Wnukiewicz J; Gutowicz J
Med Sci Monit; 2002 Dec; 8(12):BR540-4. PubMed ID: 12503033
[TBL] [Abstract][Full Text] [Related]
7. Changes in management techniques and patterns of disease recurrence over time in patients with breast carcinoma treated with breast-conserving therapy at a single institution.
Pass H; Vicini FA; Kestin LL; Goldstein NS; Decker D; Pettinga J; Ingold J; Benitez P; Neumann K; Rebner M; Dekhne N; Martinez A
Cancer; 2004 Aug; 101(4):713-20. PubMed ID: 15305400
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
Morton BA; Ramey WG; Paderon H; Miller RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
[TBL] [Abstract][Full Text] [Related]
9. Significance of intramammary lymph nodes in the staging of breast cancer: correlation with tumor characteristics and outcome.
Nassar A; Cohen C; Cotsonis G; Carlson G
Breast J; 2008; 14(2):147-52. PubMed ID: 18248563
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes.
Duraker N; Caynak ZC
Cancer; 2005 Aug; 104(4):700-7. PubMed ID: 16003773
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.
Shah FD; Shukla SN; Shah PM; Shukla HK; Patel PS
Indian J Cancer; 2009; 46(3):194-202. PubMed ID: 19574670
[TBL] [Abstract][Full Text] [Related]
12. Detection of circulating tumor cells in early-stage breast cancer metastasis to axillary lymph nodes.
Nakagawa T; Martinez SR; Goto Y; Koyanagi K; Kitago M; Shingai T; Elashoff DA; Ye X; Singer FR; Giuliano AE; Hoon DS
Clin Cancer Res; 2007 Jul; 13(14):4105-10. PubMed ID: 17634536
[TBL] [Abstract][Full Text] [Related]
13. [Performance of 18F-FDG PET/CT in the detection of primary breast cancer and staging of the regional lymph nodes].
Zhao TT; Li JG; Li YM
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):206-9. PubMed ID: 17649638
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of pyrimidine nucleoside phosphorylase (PyNPase) in breast cancer].
Seo S; Miki A; Iwaisako K; Kamo N; Inomoto T; Kitai T; Ukikusa M
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1579-82. PubMed ID: 17108722
[TBL] [Abstract][Full Text] [Related]
15. [Significance of telomerase expression in diagnosis and treatment of breast tumor].
Qiu XG; Liu YP; Pu QT; Gu QH; Han JJ
Ai Zheng; 2002 Nov; 21(11):1241-3. PubMed ID: 12526225
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
[TBL] [Abstract][Full Text] [Related]
17. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
[TBL] [Abstract][Full Text] [Related]
18. The 2003 revised TNM staging system for breast cancer: results of stage re-classification on survival and future comparisons among stage groups.
Escobar PF; Patrick RJ; Rybicki LA; Weng DE; Crowe JP
Ann Surg Oncol; 2007 Jan; 14(1):143-7. PubMed ID: 17058125
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
[TBL] [Abstract][Full Text] [Related]
20. [Functional activity of the natural killers and macrophages in patients with breast tumors].
Andrianov IG; Voronov SM; Dobkin AN; Okulov VB; Orlov AB
Vopr Onkol; 1988; 34(12):1455-60. PubMed ID: 3265236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
